Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan D Sniderman

Showing results (41-50 of 164) with videos related to

Pageof 17
Sort By:
Journal of the American College of Cardiology|March 11, 2022
Key Questions About Familial Hypercholesterolemia: JACC Review Topic of the WeekAllan D Sniderman, Tamara Glavinovic, George Thanassoulis
Journal of the American College of Cardiology|March 18, 2014
The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapiesAllan D Sniderman, Sotirios Tsimikas, Sergio Fazio
European Heart Journal|April 15, 2020
Prevention of cardiovascular disease: time for a course correctionAllan D Sniderman, George Thanassoulis, Michael Pencina
Circulation Research|May 10, 2019
ApoBAllan D Sniderman, Michael Pencina, George Thanassoulis
Circulation|December 10, 2019
Letter by Sniderman et al Regarding Article, "Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease"Allan D Sniderman, George Thanassoulis, Michael Pencina
Journal of Lipid Research|January 3, 2004
ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytesMay Faraj, Allan D Sniderman, Katherine Cianflone
The Journal of Biological Chemistry|September 24, 2002
Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob miceZhunan Xia, Allan D Sniderman, Katherine Cianflone
European Heart Journal|May 6, 2025
ApoB and Lp(a): core measures to assess cardiovascular riskAllan D Sniderman, Michael J Pencina, George Thanassoulis
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 28, 2023
Apolipoprotein B in cardiovascular risk assessmentMaud Ahmad, Allan D Sniderman, Robert A Hegele
JAMA Cardiology|November 14, 2018
A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary PreventionGeorge Thanassoulis, Allan D Sniderman, Michael J Pencina
Pageof 17

Showing results (41-50 of 164) with videos related to

Sort By:
Pageof 17
Journal of the American College of Cardiology|March 11, 2022
Key Questions About Familial Hypercholesterolemia: JACC Review Topic of the WeekAllan D Sniderman, Tamara Glavinovic, George Thanassoulis
Journal of the American College of Cardiology|March 18, 2014
The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapiesAllan D Sniderman, Sotirios Tsimikas, Sergio Fazio
European Heart Journal|April 15, 2020
Prevention of cardiovascular disease: time for a course correctionAllan D Sniderman, George Thanassoulis, Michael Pencina
Circulation Research|May 10, 2019
ApoBAllan D Sniderman, Michael Pencina, George Thanassoulis
Circulation|December 10, 2019
Letter by Sniderman et al Regarding Article, "Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease"Allan D Sniderman, George Thanassoulis, Michael Pencina
Journal of Lipid Research|January 3, 2004
ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytesMay Faraj, Allan D Sniderman, Katherine Cianflone
The Journal of Biological Chemistry|September 24, 2002
Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob miceZhunan Xia, Allan D Sniderman, Katherine Cianflone
European Heart Journal|May 6, 2025
ApoB and Lp(a): core measures to assess cardiovascular riskAllan D Sniderman, Michael J Pencina, George Thanassoulis
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 28, 2023
Apolipoprotein B in cardiovascular risk assessmentMaud Ahmad, Allan D Sniderman, Robert A Hegele
JAMA Cardiology|November 14, 2018
A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary PreventionGeorge Thanassoulis, Allan D Sniderman, Michael J Pencina
Pageof 17